|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-3-21
|
|
pubmed:abstractText |
We aimed to see if structured treatment interruption (STI) could be supported safely with the use of two cycles of IL-2 (4.5 MIU q12h subcutaneously 5 days) before STI to prolong the time before therapy restarted.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1473-5571
|
|
pubmed:author |
pubmed-author:AngusBrianB,
pubmed-author:BabikerAbdulA,
pubmed-author:ClotetBonaventuraB,
pubmed-author:DuvivierClaudineC,
pubmed-author:FisherMartinM,
pubmed-author:KatlamaChristineC,
pubmed-author:LampeFionaF,
pubmed-author:PhillipsAndrewA,
pubmed-author:PostFrank AFA,
pubmed-author:TILT Trial Steering Committee,
pubmed-author:TambussiGuiseppeG,
pubmed-author:WilliamsIanI,
pubmed-author:YouleMikeM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
30
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
737-40
|
|
pubmed:meshHeading |
pubmed-meshheading:18356603-Anti-Retroviral Agents,
pubmed-meshheading:18356603-CD4 Lymphocyte Count,
pubmed-meshheading:18356603-Combined Modality Therapy,
pubmed-meshheading:18356603-Drug Administration Schedule,
pubmed-meshheading:18356603-Follow-Up Studies,
pubmed-meshheading:18356603-HIV Infections,
pubmed-meshheading:18356603-HIV-1,
pubmed-meshheading:18356603-Homosexuality,
pubmed-meshheading:18356603-Humans,
pubmed-meshheading:18356603-Interleukin-2,
pubmed-meshheading:18356603-Male,
pubmed-meshheading:18356603-Middle Aged,
pubmed-meshheading:18356603-Viral Load
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals.
|
|
pubmed:affiliation |
Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, UK. brian.angus@ndm.ox.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
